PATENTS

15. Method for Nucleic Acid Cleavage
Mikutis S; Sib A; Bernardes GJL; GB Patent Application No: 2115540.3 (2021)

14. Production of Cross-reactive material 197 Fusion Proteins
Albuquerque I; Bernardes GJL; GB Patent Application No: 2108650.9 (2021)

13. CRM197 Protein Carrier
Albuquerque I; Bernardes GJL; GB Patent Application No: 2108648.3 (2021)

12. Ligand drug conjugates and modified BET inhibitors
Traquete R; Bernardes GJL; PCT/GB2021/050058 (2021)

11. Method for Nucleic Acids Cleavage
Mikutis S, Tzelepis K; Bernardes GJL; EP20386040.8 (2020).

10. Treatment of Immunosuppressive Cancer
Labão–Almeida C; Bernardes GJL; GB Patent Application No: 2004514.2 (2020).

9. Inhibitors of RNA-binding proteins as anti-cancer drugs
Hüttelmaier S;Bertoldo JB; Müller S; Bernardes GJL; EP Patent Application No: 20159945.3 (2020).

8. Compounds
Seixas JD; Bernardes GJL; GB Patent Application No: 1908171.0 (2019).

7. Treatment of obesity-related conditions
Domingos A; Bernardes GJL; WO 2019/076675 (2018).

6. TRPV2 Antagonists
Rodrigues T; Baker C; Conde J; Bernardes GJL; WO 2019/054891 (2018).

5. 5-Lipoxygenase Antagonists
Rodrigues T; Bernardes GJL; WO 2019/050422 (2018).

4. Methods for protein stapling
Martinez-Saez N; Sun S; Boutureira O; Corzana F; Bernardes GJL; GB Patent Application No: GB1704922.2 (2017).

3. Ruthenium carbon monoxide releasing compounds and uses thereof for treatment of inflammatory conditions
Pamplona A; Bernardes GJL; Mota MM; Romão CC; PCT/US2012047661 (2013).

2. Chemical modification of proteins by selective conversion of cysteine and alkyl cysteines to dehydroalanine on proteins surfaces as switchable access to functionalized proteins
Bernardes GJL; Chalker JM; Davis BG; PCT Int. Appl. (2009), WO 2009103941 A1 20090827.

1. Process of forming sulfide bridges using glycoside amino acids”
Davis BG; Bernardes GJL; PCT Int. Appl. (2009), WO 2009098437 A2 20090813.